Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  necitumumab
Find trials that include:  Any drugs shown
Results 1-5 of 5 for your search:
Start Over
A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 15529, NCI-2015-02258, I4X-MC-JFCP, NCT02392507
A Study of LY3023414 and Necitumumab in Squamous Lung Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 15799, NCI-2015-02015, I6A-MC-CBBE, NCT02443337
A Study of the Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475) in Participants With NSCLC
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 15568, NCI-2016-00244, 2015-001291-22, I4X-MC-JFCQ, KEYNOTE -099, NCT02451930
EGFR Inhibitor AZD9291 and Necitumumab in Treating Patients with EGFR-Positive Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: PhI-77, NCI-2015-01053, 9898, NCT02496663
A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 16088, NCI-2016-01008, 2016-000440-33, I8J-MC-JYCA, NCT02791334
Start Over